News & Analysis as of

Funding Investors

Freeman Law

Startup Funding: Using Convertible Notes and SAFEs to Bridge the Valuation Gap Between Early Investors and Founders

Freeman Law on

Many startup projects begin with small investments from founders and friends or family who believe in the founders’ plan, product, or idea. As startups further develop their business offering and concept, they often require...more

White & Case LLP

Real estate 2024: Emerging from the storm?

White & Case LLP on

The real estate sector is looking ahead with more optimism, as interest rates peak and a clearer picture forms on valuation and future financial performance - Key sections - Section 1: Market overview and outlook ...more

ArentFox Schiff

Emerging Businesses and Venture Capital in 2024: 10 Hot Topics for Founders, Investors, and Executives of Emerging Companies

ArentFox Schiff on

2023 was a pivotal year for the emerging companies, creating new categories of winners and losers across the board. Emerging companies incorporating artificial intelligence or that have clear line of sight to positive cash...more

Bass, Berry & Sims PLC

2024 Healthcare Private Equity Outlook & Trends

W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity. As we begin 2024, we have highlighted the issues and trends that...more

BCLP

Investing in your IP Rights: A Key Step to Attracting European Startup Funding

BCLP on

A recent study by the European Patent Office (EPO) and the European Union Intellectual Property Office (EUIPO) provides useful support for those working to develop and protect valuable IP rights. It reveals that European...more

Latham & Watkins LLP

Life Sciences Product Development Needs More Creative Fundraising

Latham & Watkins LLP on

The life sciences industry depended historically on public offerings for fundraising to support costs of developing therapeutic pharmaceutical and biologic products. The average cost of discovering and developing these...more

Bass, Berry & Sims PLC

Health Care Investors Conference: 2023 Recap

Bass, Berry & Sims PLC on

Funding Environment Toughest in 40 Years - The consensus of the four members of a panel on funding and financing healthcare is that the environment is tougher than they experienced in the wake of the 2008 financial crisis....more

Farrell Fritz, P.C.

Revenue Participation Rights as a Crowdfunding Instrument Alternative

Farrell Fritz, P.C. on

The anti-child trafficking thriller “Sound of Freedom” just opened in theatres on July 4th.  Based on a true story, it stars Jim Caviezal as former Homeland Security special agent Tim Ballard who quits his job with the agency...more

Lippes Mathias LLP

Venture Capital 101

Lippes Mathias LLP on

A company starts off with an idea and needs capital to secure a patent and build a prototype .At this point, the founding team’s personal resources and network are the primary source of capital. ...more

Bass, Berry & Sims PLC

Sunny Days Ahead? Key Takeaways from Bass, Berry & Sims Connect During the Annual the J.P. Morgan Healthcare Conference

Bass, Berry & Sims PLC on

Even the threat of an unprecedented atmospheric river storm could not stop the tried and true from attending the 41st annual J.P. Morgan Healthcare Conference. With a break of sunshine on Monday, we found ourselves asking,...more

Butler Snow LLP

A Dive into Third-Party Litigation Financing and Third-Party Medical Funding

Butler Snow LLP on

A few years ago, commentators estimated there was $5 billion in litigation financing in the United States. Since then, the litigation funding industry has continued to grow. For good reason, Third-Party Litigation Financing...more

Foley & Lardner LLP

Will We See the Predicted M&A Spike in 2023?

Foley & Lardner LLP on

In 2022, many predicted we would see a spike in M&A due to the economic downturn and the steep drop in startup valuations. However, last year was not the M&A blockbuster that was predicted, and we even saw a drop-off in...more

Allen Matkins

Life Sciences Real Estate Update -1.06.23 #1

Allen Matkins on

California’s lab and biotech industries provide 435,693 jobs that generate $376 billion in total economic output, according to a new report from Biocom California, an association representing life sciences companies and...more

Foley & Lardner LLP

A Look at Series A Financing Amidst the Downturn

Foley & Lardner LLP on

Are we in a downturn? I am no economist, but in the global Silicon Valley, 2022 was all about the early stage in tech. Strong headwinds in financial markets, compressed multiples leading to substantially lower...more

White & Case LLP

Middle East and Africa corridor: The perfect partnership for funding Africa's growth

White & Case LLP on

For African economies living on the edge, can the Middle East provide the much-needed boost to the under-serviced Muslim population in Africa? ...more

McDermott Will & Emery

IPEM 2022 | Key Takeaways

McDermott Will & Emery on

After an insightful conference in Cannes, our partners have compiled some of the key takeaways from IPEM 2022. As well as exploring the private equity landscape in the UK, Germany, France and Italy, we also explore the...more

White & Case LLP

The fund finance market takes flight

White & Case LLP on

Fund finance is positioned for record levels of growth as private equity (PE) general partners (GPs) tap traditional subscription and net asset value (NAV) financing lines in greater numbers....more

Bailey & Glasser, LLP

[Webinar] Raising Capital & Staying Compliant: It’s Not Easy Being Green - December 9th, 1:30 pm - 2:00 pm ET

Bailey & Glasser, LLP on

Thanks to everyone who joined Part One of Bailey Glasser’s two-part raising capital webinar series with lawyers Michael de León Hawthorne and Carlos Duque. Part One of the webinar featured raising capital questions and...more

Goodwin

Client Conversation: Square Mile Capital

Goodwin on

As investors’ demand for life sciences real estate grows at a rapid pace, lenders are actively seeking to lend in this space. Goodwin partner Jarrid King spoke with Eric Juster, Vice President, Investments at Square Mile...more

King & Spalding

Auswirkungen der OffenlegungsVO auf Bestandsfonds

King & Spalding on

Da die OffenlegungsVO nicht zwischen neu aufgelegten und bestehenden AIF unterscheidet, sondern beide unter die Definition des Finanzprodukts nach Art. 2 Nr. 12 (ii) OffenlegungsVO fasst, stellt sich für die betroffenen...more

Winstead PC

[Webinar] Investing in Universities - Intellectual Property Due Diligence: A Critical Prerequisite to Funding Startup Companies -...

Winstead PC on

Join us for a webinar series on Investing in University Startup Companies. Topics discussed include intellectual property due diligence for venture capital transactions. We are grateful for our guest panelists Technium....more

Latham & Watkins LLP

Fast Track to IPO: Why Are Series A Startups Snatching Topflight CFOs?

Latham & Watkins LLP on

Startups and scale-ups in Europe’s tech and life sciences sectors have flourished dramatically over the past year, fueled by pandemic-induced demand and a wall of investor cash. Early funding rounds are getting bigger, while...more

Bennett Jones LLP

Alberta and Saskatchewan's New Self-Certified Investor Prospectus Exemption

Bennett Jones LLP on

On March 31, 2021, securities regulators in Alberta and Saskatchewan adopted a new self-certified investor prospectus exemption, in effect for the next three years (expiring April 1, 2024), to increase capital access and...more

Foster Garvey PC

Online Travel Update: JetBlue seeks to diversify its online offerings; Hopper announces latest $170 million funding round;...

Foster Garvey PC on

Last week was a relatively quiet one for the online travel industry. Hopper garnered most of the headlines with its recent funding round (and accompanying $1 billion valuation). Enjoy....more

Butler Snow LLP

Discoverability of Third-Party Litigation Financing

Butler Snow LLP on

In litigation-funding arrangements, an investor advances money to a party—usually a plaintiff—to pay lawsuit expenses. In exchange, the borrower agrees to give the investor a portion of his proceeds from the litigation....more

36 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide